Search Within

Gregory J Riely

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (79)
  2. Meeting Abstract (49)
  3. Book Section (1)
  4. Conference Paper (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (131)
  2. Epidemiology and Biostatistics (131)
  3. Solid Tumor Oncology Division (131)
  4. Thoracic Oncology (131)
  5. Biostatistics Service (121)
  6. GSK Faculty (89)

More Groups

People
  1. Mark Kris (62)
  2. Marc Ladanyi (55)
  3. Charles Rudin (45)
  4. Helena Yu (45)
  5. Maria Arcila (38)
  6. Ronglai Shen (36)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (17)
  4. 2022 (13)
  5. 2021 (12)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (35)
  2. Journal of Thoracic Oncology (17)
  3. Clinical Cancer Research (14)
  4. International Journal of Radiation Oncology, Biology, Physics (7)
  5. JCO Precision Oncology (6)
  6. Annals of Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (42)
  2. Elsevier Inc. (25)
  3. American Association for Cancer Research (21)
  4. Oxford University Press (8)
  5. Nature Publishing Group (7)
  6. American Medical Association (6)

More Publishers

Results (131)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinoma
    Journal Article

    Gerber, N. K.; Yamada, Y.; Rimner, A.; Shi, W.; Riely, G. J.; Beal, K.; Yu, H. A.; Chan, T. A.; Zhang, Z.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Comparison of the characteristics and clinical course of 677 patients with metastatic lung cancers with mutations in KRAS codons 12 and 13
    Meeting Abstract

    Yu, H. A.; Sima, C. S.; Shen, R. L.; Kass, S. L.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Comparison of the characteristics and clinical course of patients with metastatic KRAS mutant lung cancers
    Meeting Abstract

    Riely, G.; Yu, H. A.; Sima, C. S.; Shen, R. L.; Kass, S. L.; Kris, M. G.; Ladanyi, M.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Gerber, N. K.; Yamada, Y.; Shi, W. J.; Zhang, Z. G.; Riely, G.; Beal, K.; Yu, H. A.; Chan, T. A.; Rimner, A.; Wu, A. J.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Distinct clinical course of EGFR-mutant resected lung cancers: Results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib
    Journal Article

    D'Angelo, S. P.; Janjigian, Y. Y.; Ahye, N.; Riely, G. J.; Chaft, J. E.; Sima, C. S.; Shen, R.; Zheng, J.; Dycoco, J.; Kris, M. G.; more...
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: Higher susceptibility of women to smoking-related KRAS-mutant cancers
    Journal Article

    Dogan, S.; Shen, R.; Ang, D. C.; Johnson, M. L.; D'Angelo, S. P.; Paik, P. K.; Brzostowski, E. B.; Riely, G. J.; Kris, M. G.; Zakowski, M. F.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/ IV nonsmall cell lung cancer
    Journal Article

    Janjigian, Y. Y.; Mcdonnell, K.; Kris, M. G.; Shen, R.; Sima, C. S.; Bach, P. B.; Rizvi, N. A.; Riely, G. J.
    Cancer (2010)

    Fulltext@MSK | Save
  • Analysis of genetic variants in never-smokers with lung cancer facilitated by an internet-based blood collection protocol: A preliminary report
    Journal Article

    Girard, N.; Lou, E.; Azzoli, C. G.; Reddy, R.; Robson, M.; Harlan, M.; Orlow, I.; Yatabe, Y.; Nafa, K.; Ladanyi, M.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations
    Meeting Abstract

    Janjigian, Y. Y.; Park, B. J.; Kris, M. G.; Miller, V. A.; Riely, G. J.; Zheng, J.; Dycoco, J. P.; Shen, R.; Azzoli, C. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Prognostic implications of EGFR and KRAS gene mutations in resected lung adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Kris, M. G.; Pao, W.; Marks, J.; Zheng, J.; Shen, R.; Dycoco, J.; Park, B. J.; Riely, G. J.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save